文献速递临床试验与 GCP

加速康复外科(ERAS)路径用于初次髋膝关节置换术:随机对照试验研究方案

Enhanced recovery after surgery (ERAS) pathway for primary hip and knee arthroplasty: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2019-10-22

本研究为前瞻性、开放标签、多中心随机对照试验,计划纳入640例初次全髋或全膝关节置换术患者,随机分为ERAS路径组和常规护理组,主要结局为总住院时间,次要结局包括术后住院时间、术后30天全因死亡率、院内并发症、早期活动、术后疼痛控制、总住院费用和出院后30天再入院率,旨在验证ERAS路径在缩短住院时间方面的优效性。

要点

  • ERAS路径组与常规护理组按参与中心随机分组,计划纳入640例初次THA或TKA患者。
  • 主要结局为总住院时间,次要结局包括术后住院时间、30天全因死亡率、院内并发症等。
  • 试验注册于美国国立卫生研究院临床试验注册库,注册号NCT03517098,注册日期2018年5月4日。

核心结论

  • 本试验旨在评估ERAS路径相较于常规非ERAS临床实践在缩短住院时间方面的优效性,结果可能为ERAS路径在THA和TKA中的临床应用提供新见解。

研究设计与样本

  • 前瞻性、开放标签、多中心随机对照试验,计划纳入640例初次全髋或全膝关节置换术患者,按参与中心随机分配至ERAS路径组或常规护理组。

关键数值与推荐

  • 主要结局为总住院时间;次要结局包括术后住院时间、术后30天全因死亡率、院内并发症、早期活动、术后疼痛控制、总住院费用和出院后30天再入院率。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: With the substantially growing trend of the aging populations in China and the rest of the world, the number of total hip and total knee arthroplasty (THA and TKA) cases are increasing dramatically. It is important to develop practical strategies to improve the quality of healthcare and better outcome for patients undergoing THA and TKA. Enhanced recovery after surgery (ERAS) pathways have been reported to promote earlier recovery and be beneficial for patients. We propose the hypothesis that the ERAS pathway could reduce the length of stay (LOS) in hospital for patients undergoing primary THA or TKA. METHODS/DESIGN: This trial is a prospective, open-labelled, multi-centered, randomized controlled trial that will test the superiority of the ERAS pathway in term of LOS in hospital for the patients undergoing primary THA or TKA compared to current non-ERAS clinical practice. A total of 640 patients undergoing primary THA or TKA will be randomly allocated to either ERAS pathway (ERAS group) or conventional care according to individual participating center (non-ERAS group). The primary outcome is the total LOS in hospital; the secondary outcomes include postoperative LOS, all-cause mortality by 30 days after operation, in-hospital complications, early mobilization, postoperative pain control, total in-hospital cost, and readmission rate by 30 days after discharge from the hospital. DISCUSSION: This trial is designed to evaluate the superiority of the ERAS pathway to conventional non-ERAS clinical practice in reducing the LOS. The results may provide new insight into the clinical applications of the ERAS pathway for THA and TKA. TRIAL REGISTRATION: National Institutes of Health Clinical Trials Registry, NCT03517098 . Registered on 4 May 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Li J, Zhu H, Liao R, et al. Enhanced recovery after surgery (ERAS) pathway for primary hip and knee arthroplasty: study protocol for a randomized controlled trial. Trials. 2019. PMID: 31640757. doi:10.1186/s13063-019-3706-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。